In addition to HBV and liver cancer, the cGAS–STING pathway has been shown to be activated in other kinds of liver diseases (e.g., non-alcoholic fatty liver disease (NAFLD), alcohol liver disease (ALD), liver ischemia–reperfusion, etc.). The gene discussed is STING1; the disease is liver disorder.